These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Tuberculosis and HIV infection: a global perspective. Murray JF Respiration; 1998; 65(5):335-42. PubMed ID: 9782213 [TBL] [Abstract][Full Text] [Related]
3. [1995 status of tuberculosis]. Schütt-Gerowitt H Fortschr Med; 1995 Mar; 113(9):115-9. PubMed ID: 7759041 [TBL] [Abstract][Full Text] [Related]
4. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
6. Estimation of the impact of the human immunodeficiency virus infection on tuberculosis: tuberculosis risks re-visited? Lienhardt C; Rodrigues LC Int J Tuberc Lung Dis; 1997 Jun; 1(3):196-204. PubMed ID: 9432364 [TBL] [Abstract][Full Text] [Related]
7. [The worldwide status of tuberculosis today]. Billo NE Pneumologie; 1995 Dec; 49 Suppl 3():633-5. PubMed ID: 8577667 [No Abstract] [Full Text] [Related]
8. [Possible effects of acquired immunologic deficiency syndrome (AIDS) on tuberculosis in industrial and developing countries]. Styblo K Pneumologie; 1990 Feb; 44 Suppl 1():647-52. PubMed ID: 2367492 [TBL] [Abstract][Full Text] [Related]
9. [Epidemiology of multidrug-resistant tuberculosis in the United States of America]. Plum G; Wenzel RP Internist (Berl); 1995 Oct; 36(10):980-6. PubMed ID: 7499074 [No Abstract] [Full Text] [Related]
10. Tuberculosis and HIV infection: global perspectives. Murray JF Respirology; 1997 Sep; 2(3):209-13. PubMed ID: 9400683 [TBL] [Abstract][Full Text] [Related]
12. [HIV-associated tuberculosis in Africa exemplified by Zimbabwe]. Schoch OD Schweiz Med Wochenschr; 1997 Jul; 127(29-30):1223-8. PubMed ID: 9333931 [TBL] [Abstract][Full Text] [Related]
13. Risk factors and outcome of human immunodeficiency virus-infected patients with sporadic multidrug-resistant tuberculosis in New York City. Mannheimer SB; Sepkowitz KA; Stoeckle M; Friedman CR; Hafner A; Riley LW Int J Tuberc Lung Dis; 1997 Aug; 1(4):319-25. PubMed ID: 9432387 [TBL] [Abstract][Full Text] [Related]
14. [Reappearance of tuberculosis, risks and consequences!]. Exner-Freisfeld H Gesundheitswesen; 1995 Dec; 57(12):798-805. PubMed ID: 8580609 [TBL] [Abstract][Full Text] [Related]
16. Will DOTS do it? A reappraisal of tuberculosis control in countries with high rates of HIV infection. De Cock KM; Chaisson RE Int J Tuberc Lung Dis; 1999 Jun; 3(6):457-65. PubMed ID: 10383056 [TBL] [Abstract][Full Text] [Related]
17. Hospital infection control in an era of HIV infection and multi-drug resistant tuberculosis. Hannan MM; Azadian BS; Gazzard BG; Hawkins DA; Hoffman PN J Hosp Infect; 2000 Jan; 44(1):5-11. PubMed ID: 10633047 [TBL] [Abstract][Full Text] [Related]
18. Tuberculosis in those with HIV infection. Thomas MG; Ellis-Pegler RB N Z Med J; 1997 Sep; 110(1052):352-4. PubMed ID: 9364176 [TBL] [Abstract][Full Text] [Related]
19. HIV infection and antituberculosis drug resistance among pulmonary tuberculosis patients in Harar Tuberculosis Centre, Ethiopia. Mitike G; Kebede D; Yeneneh H East Afr Med J; 1997 Mar; 74(3):154-7. PubMed ID: 9185411 [TBL] [Abstract][Full Text] [Related]
20. Multidrug-resistant tuberculosis at an HIV testing center in Haiti. Joseph P; Severe P; Ferdinand S; Goh KS; Sola C; Haas DW; Johnson WD; Rastogi N; Pape JW; Fitzgerald DW AIDS; 2006 Feb; 20(3):415-8. PubMed ID: 16439875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]